This Week in Nature

In a paper published online in advance in Nature this week, researchers at the Northwestern University Feinberg School of Medicine and elsewhere report that mutations in UBQLN2 — which encodes the ubiquitin-like protein ubiquilin 2 — "cause dominantly inherited, chromosome-X-linked ALS [amyotrophic lateral sclerosis] and ALS/dementia." In its functional analyses, the team found evidence linking "abnormalities in ubiquilin 2 to defects in the protein degradation pathway, abnormal

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.